Last reviewed · How we verify
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
The purpose of this study is to determine if the combination of paclitaxel protein bound, gemcitabine, cisplatin, paricalcitol are effective in individuals with previously untreated metastatic pancreatic cancer.
Details
| Lead sponsor | HonorHealth Research Institute |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 11 |
| Start date | Wed Jan 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Adenocarcinoma
- Pancreas Metastases
- Adenocarcinoma
Interventions
- Paricalcitol (Zemplar)
Countries
United States